Pfiz­er calls pro­posed IP waiv­er for Covid vac­cines a 'dis­trac­tion' from find­ing re­al so­lu­tions on ac­cess

While it seems ob­vi­ous that Pfiz­er would op­pose any move at the World Trade Or­ga­ni­za­tion to waive the com­pa­ny’s in­tel­lec­tu­al prop­er­ty rights, the mR­NA pow­er­house …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER